KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Capital Expenditures (2016 - 2026)

Edwards Lifesciences has reported Capital Expenditures over the past 17 years, most recently at $97.4 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 95.58% year-over-year to $97.4 million; the TTM value through Dec 2025 reached $260.2 million, up 3.09%, while the annual FY2025 figure was $260.2 million, 3.09% up from the prior year.
  • Capital Expenditures for Q4 2025 was $97.4 million at Edwards Lifesciences, up from $57.5 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $106.0 million in Q1 2021 and troughed at $43.1 million in Q2 2022.
  • A 5-year average of $66.8 million and a median of $61.1 million in 2021 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: tumbled 43.6% in 2024 and later soared 95.58% in 2025.
  • Year by year, Capital Expenditures stood at $89.8 million in 2021, then dropped by 23.27% to $68.9 million in 2022, then rose by 28.16% to $88.3 million in 2023, then tumbled by 43.6% to $49.8 million in 2024, then soared by 95.58% to $97.4 million in 2025.
  • Business Quant data shows Capital Expenditures for EW at $97.4 million in Q4 2025, $57.5 million in Q3 2025, and $49.3 million in Q2 2025.